Review of Adjuvant Therapies in Renal Cell Carcinoma: Evidence to Date.

Tacconi, Eliana M C; Tuthill, Mark; Protheroe, Andrew

Tacconi, Eliana M C; Tuthill, Mark; Protheroe, Andrew.

Afiliación

Tacconi EMC; Department of Oncology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK.
Tuthill M; Department of Oncology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK.
Protheroe A; Department of Oncology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK.

Onco Targets Ther ; 13: 12301-12316, 2020.

Article en En | MEDLINE | ID: mdl-33299326

Palabras clave

adjuvant therapy; immune checkpoint inhibitors; renal cell carcinoma; tyrosine kinase inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Onco Targets Ther Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google